Skip to main content
SpringerLink
Log in

Apoptosis Control Based on Down-Regulating the Inhibitor-of-Apoptosis (IAP) Proteins: Xiap Antisense and Other Approaches

  • Chapter
Cell Engineering

Part of the book series: Cell Engineering ((CEEN,volume 4))

  • 745 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Agrawal S. (1999) Importance of nucleotide sequence and chemical modifications of antisenseoligonucleotides. Biochim Biophys Acta. 1489, 53–68

    CAS  PubMed  Google Scholar 

  • Agrawal S, and Kandimalla ER. (2000) Antisense therapeutics: is it as simple as complementary base recognition? Mol Med Today. 6, 72–81.

    CAS  PubMed  Google Scholar 

  • Altieri DC. (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer. 3, 46–54

    Article  CAS  PubMed  Google Scholar 

  • Ambrosini G, Adida C, and Altieri DC. (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 3, 917–921.

    Article  CAS  PubMed  Google Scholar 

  • Ambrosini G, Adida C, Sirugo G, and Altieri DC. (1998) Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273, 11177–11182.

    Article  CAS  PubMed  Google Scholar 

  • Aoki Y, Cioca DP, Oidaira H, and Kiyosawa K (2003) RNA interference may be more potent than antisense RNA in human cancer cell lines. Clin Exp Pharmacol Physiol 30, 96–102

    Article  CAS  PubMed  Google Scholar 

  • Asselin E, Mills GB, and Tsang BK. (2001a) XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Cancer Res. 61, 1862–1868.

    CAS  PubMed  Google Scholar 

  • Asselin E, Wang Y, and Tsang BK. (2001b) X-linked inhibitor of apoptosis protein activates the phosphatidylinositol 3-kinase/Akt pathway in rat granulosa cells during follicular development. Endocrinology. 142, 2451–2457.

    Article  CAS  PubMed  Google Scholar 

  • Barton GM, and Medzhitov R (2002) Retroviral delivery of small interfering RNA into primary cells. Proc Natl Acad Sci USA 99: 14943–14945

    CAS  PubMed  Google Scholar 

  • Benimetskaya L, Tonkinson J, and Stein CA. (2000) Determination of cellular internalization of fluoresceinated oligonucleotides. Methods Enzymol. 313, 287–297.

    CAS  PubMed  Google Scholar 

  • Bertrand JR, Pottier M, Vekris A, Opolon P, Maksimenko A, and Malvy C. (2002) Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun. 296, 1000–1004.

    Article  CAS  PubMed  Google Scholar 

  • Bhagat L, Zhu FG, Yu D, Tang J, Wang H, Kandimalla ER, Zhang R, and Agrawal S. (2003) CpG penta-and hexadeoxyribonucleotides as potent immunomodulatory agents. Biochem Biophys Res Commun. 300, 853–861.

    Article  CAS  PubMed  Google Scholar 

  • Bilim V, Kasahara T, Hara N, Takahashi K, and Tomita Y. (2003) Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro. Int J Cancer. 103, 29–37.

    Article  CAS  PubMed  Google Scholar 

  • Bohula EA, Salisbury AJ, Sohail M, Playford MP, Riedemann J, Southern EM, and Macaulay VM (2003) The efficacy of small interfering RNAs targeted to the type 1 IGF receptor is influenced by secondary structure in the IGF1R transcript. J Biol Chem (missing vol and page info, epub on Feb 24)

    Google Scholar 

  • Braasch DA, Jensen S, Liu Y, Kaur K, Arar K, White MA, and Corey DR. (2003) RNA Interference in Mammalian Cells by Chemically-Modified RNA. Biochemistry. 42, 7967–7975.

    Article  CAS  PubMed  Google Scholar 

  • Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, and Iggo R. (2003) Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet. 34, 263–264.

    Article  CAS  PubMed  Google Scholar 

  • Brigui I, Djavanbakht-Samani T, Jolles B, Pigaglio S, and Laigle A. (2003) Minimally modified phosphodiester antisense oligodeoxyribonucleotide directed against the multidrug resistance gene mdr1. Biochem Pharmacol. 65, 747–754.

    Article  CAS  PubMed  Google Scholar 

  • Brummelkamp TR, Bernards R, and Agami R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science. 296, 550–553.

    Article  CAS  PubMed  Google Scholar 

  • Brummelkamp TR, Bernards R, and Agami R. (2002) Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell. 2, 243–247.

    Article  CAS  PubMed  Google Scholar 

  • Carmell MA, Zhang L, Conklin DS, Hannon GJ, and Rosenquist TA. (2003) Germline transmission of RNAi in mice. Nat Struct Biol. 10, 91–92.

    Article  CAS  PubMed  Google Scholar 

  • Carvalho A, Carmena M, Sambade C, Earnshaw WC, and Wheatley SP. (2003) Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. J Cell Sci. 116, 2987–2998.

    Article  CAS  PubMed  Google Scholar 

  • Casamassimi A, De Luca A, Agrawal S, Stromberg K, Salomon DS, and Normanno N. (2000) EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells. Ann Oncol. 11, 319–325.

    Article  CAS  PubMed  Google Scholar 

  • Chen Z, Naito M, Hori S, Mashima T, Yamori T, and Tsuruo T. (1999) A human IAP-family gene, apollon, expressed in human brain cancer cells. Biochem Biophys Res Commun. 264, 847–854.

    Article  CAS  PubMed  Google Scholar 

  • Chen J, Wu W, Tahir SK, Kroeger PE, Rosenberg SH, Cowsert LM, Bennett F, Krajewski S, Krajewska M, Welsh K, Reed JC, and Ng SC. (2000) Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. Neoplasia. 2, 235–241.

    Article  CAS  PubMed  Google Scholar 

  • Chen J, Jin S, Tahir SK, Zhang H, Liu X, Sarthy AV, McGonigal TP, Liu Z, Rosenberg SH, and Ng SC. (2003) Survivin enhances Aurora-B kinase activity and localizes Aurora-B in human cells. J Biol Chem. 278, 486–490.

    CAS  PubMed  Google Scholar 

  • Choi KS, Lee TH, and Jung MH. (2003) Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells. Cancer Gene Ther. 10, 87–95.

    Article  CAS  PubMed  Google Scholar 

  • Czauderna F, Fechtner M, Dames S, Aygun H, Klippel A, Pronk GJ, Giese K, and Kaufmann J. (2003) Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 31, 2705–2716.

    CAS  PubMed  Google Scholar 

  • Dai Z, Zhu WG, Morrison CD, Brena RM, Smiraglia DJ, Raval A, Wu YZ, Rush LJ, Ross P, Molina JR, Otterson GA, and Plass C. (2003) A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. Hum Mol Genet. 12, 791–801.

    Article  CAS  PubMed  Google Scholar 

  • De Luca A, Selvam MP, Sandomenico C, Pepe S, Bianco AR, Ciardiello F, Salomon DS, Normanno N. (1997) Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells. Int J Cancer. 73, 277–282.

    PubMed  Google Scholar 

  • Deveraux QL, Takahashi R, Salvesen GS, and Reed JC. (1997) X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 388, 300–304.

    CAS  PubMed  Google Scholar 

  • Dierlamm J, Baens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez JM, Hossfeld DK, De Wolf-Peeters C, Hagemeijer A, Van den Berghe H, and Marynen P. (1999) The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood. 93, 3601–3609.

    CAS  PubMed  Google Scholar 

  • Dykxhoorn DM, Novina CD, and Sharp PA (2003) Killing the messenger: short RNAs that silence gene expression. Nature Rev Mol Cell Biol 4, 457–467

    CAS  Google Scholar 

  • Earnshaw WC, Martins LM, and Kaufmann SH. (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem. 68, 383–424.

    Article  CAS  PubMed  Google Scholar 

  • Erl W, Hansson GK, de Martin R, Draude G, Weber KS, and Weber C. (1999) Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res. 84, 668–677.

    CAS  PubMed  Google Scholar 

  • Evan G, and Littlewood T. (1998) A matter of life and cell death. Science. 281, 1317–1322.

    Article  CAS  PubMed  Google Scholar 

  • Far RKK, Nedbal W, and Sczakiel G (2001) Concepts to automate the theoretical design of effective antisense oligonucleotides. Bioinformatics 17, 1058–1061

    CAS  PubMed  Google Scholar 

  • Fraser AG, James C, Evan GI, and Hengartner MO. (1999) Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr Biol. 9, 292–301.

    Article  CAS  PubMed  Google Scholar 

  • Gordon GJ, Appasani K, Parcells JP, Mukhopadhyay NK, Jaklitsch MT, Richards WG, Sugarbaker DJ, and Bueno R. (2002) Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma. Carcinogenesis. 23, 1017–1024.

    Article  CAS  PubMed  Google Scholar 

  • Grossman D, McNiff JM, Li F, and Altieri DC. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol. 113, 1076–1081

    Google Scholar 

  • Grossman D, McNiff JM, Li F, and Altieri DC. (1999) Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest. 79, 1121–1126.

    CAS  PubMed  Google Scholar 

  • Grunweller A, Wyszko E, Bieber B, Jahnel R, Erdmann VA, and Kurreck J. (2003) Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′-O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res. 31, 3185–3193.

    Article  PubMed  Google Scholar 

  • Hamada M, Ohtsuka T, Kawaida R, Koizumi M, Morita K, Furukawa H, Imanishi T, Miyagishi M, and Taira K. (2002) Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3′-ends of siRNAs. Antisense Nucleic Acid Drug Dev. 12, 301–309.

    Article  CAS  PubMed  Google Scholar 

  • Hanahan D, and Weinberg RA. (2000) The hallmarks of cancer. Cell. 100, 57–70.

    Article  CAS  PubMed  Google Scholar 

  • Hemann MT, Fridman JS, Zilfou JT, Hernando E, Paddison PJ, Cordon-Cardo C, Hannon GJ, and Lowe SW. (2003) An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet. 33, 396–400.

    Article  CAS  PubMed  Google Scholar 

  • Holcik M, Yeh C, Korneluk RG, and Chow T. (2000) Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene. 19, 4174–4177.

    Article  CAS  PubMed  Google Scholar 

  • Holcik M, and Korneluk RG. (2001) XIAP, the guardian angel. Nat Rev Mol Cell Biol. 2, 550–556.

    Article  CAS  PubMed  Google Scholar 

  • Holen T, Amarzguioui M, Babaie E, and Prydz H (2003) Similar behaviour of single-strand and double-strabd si RNAs suggests they act through a common RNAi pathway. Nucleic Acids Res 31, 2401–2407

    Article  CAS  PubMed  Google Scholar 

  • Hough SR, Wiederholt KA, Burrier AC, Woolf TM, and Taylor MF. (2003) Why RNAi makes sense. Nat Biotechnol. 21, 731–732

    Article  CAS  PubMed  Google Scholar 

  • Hu Y, Cherton-Horvat G, Dragowska V, Baird S, Korneluk RG, Durkin JP, Mayer LD, and LaCasse EC. (2003) Antisense Oligonucleotides Targeting XIAP Induce Apoptosis and Enhance Chemotherapeutic Activity against Human Lung Cancer Cells in Vitro and in Vivo. Clin Cancer Res. 9, 2826–36.

    CAS  PubMed  Google Scholar 

  • Igney FH, and Krammer PH. (2002) Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2, 277–288.

    Article  CAS  PubMed  Google Scholar 

  • Imoto I, Yang ZQ, Pimkhaokham A, Tsuda H, Shimada Y, Imamura M, Ohki M, and Inazawa J. (2001) Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res. 61, 6629–6634.

    CAS  PubMed  Google Scholar 

  • Imoto I, Tsuda H, Hirasawa A, Miura M, Sakamoto M, Hirohashi S, and Inazawa J. (2002) Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy. Cancer Res. 62, 4860–4866.

    CAS  PubMed  Google Scholar 

  • Jansen B, and Zangemeister-Wittke U. (2002) Antisense therapy for cancer—the time of truth. Lancet Oncol. 3, 672–683.

    Article  CAS  PubMed  Google Scholar 

  • Jansen B, Wacheck V, Heere-Ress E, Schlagbauer-Wadl H, Hoeller C, Lucas T, Hoermann M, Hollenstein U, Wolff K, and Pehamberger H. (2000) Chemosensitisation of malignant melanoma by BCL2 antisense therapy. Lancet. 356, 1728–1733.

    Article  CAS  PubMed  Google Scholar 

  • Kallio MJ, Nieminen M, and Eriksson JE. (2001) Human inhibitor of apoptosis protein (IAP) survivin participates in regulation of chromosome segregation and mitotic exit. FASEB J. 15, 2721–2723.

    CAS  PubMed  Google Scholar 

  • Kandimalla ER, Yu D, and Agrawal S (2002) Towards optimal design of second-generation immunostimulatory oligonucleotides. Curr Opin Mol Ther 4, 122–129

    CAS  PubMed  Google Scholar 

  • Kanwar JR, Shen WP, Kanwar RK, Berg RW, and Krissansen GW. (2001) Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy. J Natl Cancer Inst. 93, 1541–1552.

    CAS  PubMed  Google Scholar 

  • Kasof GM, and Gomes BC. (2001) Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem. 276, 3238–3246.

    Article  CAS  PubMed  Google Scholar 

  • Kunath T, Gish G, Lickert H, Jones N, Pawson T, and Rossant J. (2003) Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat Biotechnol. 21, 559–561.

    Article  CAS  PubMed  Google Scholar 

  • LaCasse EC, Baird S, Korneluk RG, and MacKenzie AE. (1998) The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 17, 3247–3259.

    Google Scholar 

  • Len SM, Wolthuis RM, Klompmaker R, Kauw J, Agami R, Brummelkamp T, Kops G, and Medema RH. (2003) Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension. EMBO J. 22, 2934–2947.

    Google Scholar 

  • Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, and Herweijer H. (2002) Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet. 32, 107–108.

    Article  CAS  PubMed  Google Scholar 

  • Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, Tognin S, Villa A, Marchisio PC, and Altieri DC. (1999) Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol. 1, 461–466.

    Article  CAS  PubMed  Google Scholar 

  • Li J, Feng Q, Kim JM, Schneiderman D, Liston P, Li M, Vanderhyden B, Faught W, Fung MF, Senterman M, Korneluk RG, and Tsang BK. (2001) Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins. Endocrinology. 142, 370–380.

    CAS  PubMed  Google Scholar 

  • Lin H, Chen C, and Chen BD. (2001) Resistance of bone marrow-derived macrophages to apoptosis is associated with the expression of X-linked inhibitor of apoptosis protein in primary cultures of bone marrow cells. Biochem J. 353, 299–306.

    Article  CAS  PubMed  Google Scholar 

  • Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A, and Korneluk RG. (1996) Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature. 379, 349–353.

    CAS  PubMed  Google Scholar 

  • Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW, and Korneluk RG. (2001) Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat Cell Biol. 3, 128–133.

    Article  CAS  PubMed  Google Scholar 

  • Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, Hamoudi RA, Diss TC, Dogan A, Megraud F, Rambaud JC, Du MQ, and Isaacson PG. (2001) Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet. 357, 39–40.

    Article  CAS  PubMed  Google Scholar 

  • Martinez LA, Naguibneva I, Lehrmann H, Vervisch A, Tchenio T, Lozano G, and Harel-Bellan A (2002) Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways. Proc Natl Acad Sci USA 99: 14849–14854

    CAS  PubMed  Google Scholar 

  • McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, and Kay MA. (2002) RNA interference in adult mice. Nature. 418, 38–39.

    Article  CAS  PubMed  Google Scholar 

  • McManus MT, and Sharp PA (2002) Gene silencing in mammals by small interfering RNAs. Nature Rev Genet 3, 737–747

    CAS  Google Scholar 

  • Mesri M, Morales-Ruiz M, Ackermann EJ, Bennett CF, Pober JS, Sessa WC, and Altieri DC. (2001) Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol. 158, 1757–1765.

    CAS  PubMed  Google Scholar 

  • Miller LK. (1999) An exegesis of IAPs: salvation and surprises from BIR motifs. Trends Cell Biol. 9, 323–328.

    Article  CAS  PubMed  Google Scholar 

  • Miller VM, Xia H, Marrs GL, Gouvion CM, Lee G, Davidson BL, and Paulson HL. (2003) Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci U S A. 100, 7195–7200.

    CAS  PubMed  Google Scholar 

  • Miranda MB, Dyer KF, Grandis JR, and Johnson DE. (2003) Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation: a requirement for Bcl-X(L) and XIAP in the prolonged survival of monocytic cells. Leukemia. 17, 390–400.

    Article  CAS  PubMed  Google Scholar 

  • [No authors listed] (2002) Hybridon and Aegera collaborate to develop antisense drug. Expert Rev Anticancer Ther. 2, 483–484.

    Google Scholar 

  • Olie RA, Simoes-Wust AP, Baumann B, Leech SH, Fabbro D, Stahel RA, and Zangemeister-Wittke U. (2000) A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res. 60, 2805–2809.

    CAS  PubMed  Google Scholar 

  • Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, and Conklin DS. (2002a) Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16, 948–958.

    Article  CAS  PubMed  Google Scholar 

  • Paddison PJ, Caudy AA, and Hannon GJ. (2002b) Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci U S A. 99, 1443–1448.

    Article  CAS  PubMed  Google Scholar 

  • Paddison PJ, and Hannon GJ. (2002) RNA interference: the new somatic cell genetics? Cancer Cell. 2, 17–23.

    Article  CAS  PubMed  Google Scholar 

  • Pennati M, Colella G, Folini M, Citti L, Daidone MG, and Zaffaroni N. (2002) Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis. J Clin Invest. 109, 285–286.

    Article  CAS  PubMed  Google Scholar 

  • Perrelet D, Ferri A, Liston P, Muzzin P, Korneluk RG, and Kato AC. (2002) IAPs are essential for GDNF-mediated neuroprotective effects in injured motor neurons in vivo. Nat Cell Biol. 4, 175–179.

    Article  CAS  PubMed  Google Scholar 

  • Peyman A, and Uhlmann E. (1996) Minimally modified oligonucleotides — combination of end-capping and pyrimidine-protection. Biol Chem Hoppe Seyler. 377, 67–70.

    CAS  PubMed  Google Scholar 

  • Pirollo KF, Rait A, Sleer LS, and Chang EH (2003) Antisense therapeutics: from theory to clinical practice. Pharmacol Therapeut 99, 55–77

    CAS  Google Scholar 

  • Reed JC. (2002) Apoptosis-based therapies. Nat Rev Drug Discov. 1, 111–121.

    Article  CAS  PubMed  Google Scholar 

  • Reed JC. (2003) Apoptosis-targeted therapies for cancer. Cancer Cell. 3, 17–22.

    Article  CAS  PubMed  Google Scholar 

  • Romano A, Guse A, Krascenicova I, Schnabel H, Schnabel R, and Glotzer M. (2003) CSC-1: a subunit of the Aurora B kinase complex that binds to the survivin-like protein BIR-1 and the incenp-like protein ICP-1. J Cell Biol. 161, 229–236.

    Article  CAS  PubMed  Google Scholar 

  • Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R, et al (1995) The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80, 167–178

    Article  CAS  PubMed  Google Scholar 

  • Roy N, Deveraux QL, Takahashi R, Salvesen GS, and Reed JC. (1997) The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 16, 6914–6925.

    CAS  PubMed  Google Scholar 

  • Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Ihrig MM, McManus MT, Gertler FB, Scott ML, and Van Parijs L. (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet. 33, 401–406.

    Article  CAS  PubMed  Google Scholar 

  • Salvesen GS, and Duckett CS. (2002) IAP proteins: blocking the road to death’s door. Nat Rev Mol Cell Biol. 3, 401–410.

    Article  CAS  PubMed  Google Scholar 

  • Samani TD, Jolles B, and Laigle A. (2001) Best minimally modified antisense oligonucleotides according to cell nuclease activity. Antisense Nucleic Acid Drug Dev. 11, 129–136.

    CAS  PubMed  Google Scholar 

  • Sasaki H, Sheng Y, Kotsuji F, and Tsang BK. (2000) Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res. 60, 5659–5666.

    CAS  PubMed  Google Scholar 

  • Shankar SL, Mani S, O’Guin KN, Kandimalla ER, Agrawal S, and Shafit-Zagardo B. (2001) Survivin inhibition induces human neural tumor cell death through caspase-independent and-dependent pathways. J Neurochem. 79, 426–436.

    Article  CAS  PubMed  Google Scholar 

  • Shen C, Buck A, Polat B, Schmid-Kotsas A, Matuschek C, Gross HJ, Bachem M, and Reske SN. (2003) Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells. Cancer Gene Ther. 10, 403–410.

    Article  CAS  PubMed  Google Scholar 

  • Shi Y (2003) Mammalian RNAi for the masses. Trends Genet 19, 9–12

    Article  PubMed  Google Scholar 

  • Shuey DJ, McCallus DE, and Giordano T (2002) RNAi: gene-silencing in therapeutic intervention. Drug Discov Today 7, 1040–1046

    Article  CAS  PubMed  Google Scholar 

  • Silke J, and Vaux DL. (2001) Two kinds of BIR-containing protein-inhibitors of apoptosis, or required for mitosis. J Cell Sci. 114, 1821–1827.

    CAS  PubMed  Google Scholar 

  • Smith L, Andersen KB, Hovgaard L, and Jaroszewski JW. (2000) Rational selection of antisense oligonucleotide sequences. Eur J Pharm Sci. 11, 191–198.

    CAS  PubMed  Google Scholar 

  • Sohail M, and Southern EM. (2000) Selecting optimal antisense reagents. Adv Drug Deliv Rev. 44, 23–34.

    Article  CAS  PubMed  Google Scholar 

  • Sohail M, Doran G, Riedemann J, Macaulay V, and Southern EM. (2003) A simple and costeffective method for producing small interfering RNAs with high efficacy. Nucleic Acids Res. 31, e38.

    Article  PubMed  Google Scholar 

  • Sommer KW, Schamberger CJ, Schmidt GE, Sasgary S, and Cerni C. (2003) Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras. Oncogene. 22, 4266–4280.

    Article  CAS  PubMed  Google Scholar 

  • Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, Chen J, and Shankar P, Lieberman J. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med. 9, 347–351.

    Article  CAS  PubMed  Google Scholar 

  • Sorensen DR, Leirdal M, and Sioud M. (2003) Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol. 327, 761–766.

    CAS  PubMed  Google Scholar 

  • Spalding AC, Jotte RM, Scheinman RI, Geraci MW, Clarke P, Tyler KL, and Johnson GL. (2002) TRAIL and inhibitors of apoptosis are opposing determinants for NF-kappaB-dependent, genotoxin-induced apoptosis of cancer cells. Oncogene. 21, 260–271.

    Article  CAS  PubMed  Google Scholar 

  • Speliotes EK, Uren A, Vaux D, and Horvitz HR. (2000) The survivin-like C. elegans BIR-1 protein acts with the Aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone Mol Cell. 6, 211–223.

    Article  CAS  PubMed  Google Scholar 

  • Stein CA. (2001) The experimental use of antisense oligonucleotides: a guide for the perplexed. J Clin Invest. 108, 641–644.

    Article  CAS  PubMed  Google Scholar 

  • Stein P, Svoboda P, and Schultz RM. (2003) Transgenic RNAi in mouse oocytes: a simple and fast approach to study gene function. Dev Biol. 256, 187–193.

    Article  CAS  PubMed  Google Scholar 

  • Stennicke HR, Ryan CA, and Salvesen GS (2002) Reprieval from execution: the molecular basis of caspase inhibition. Trends Biochem Sci 27, 94–101

    Article  CAS  PubMed  Google Scholar 

  • Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, Weinberg RA, and Novina CD. (2003) Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA. 9, 493–501.

    Article  CAS  PubMed  Google Scholar 

  • Sussman HE (2003) Success for oral antisense therapy. Drug Discov Today 8, 516–517

    PubMed  Google Scholar 

  • Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, Andreeff M, and Reed JC. (2000) Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res. 6, 1796–1803.

    CAS  PubMed  Google Scholar 

  • Thompson JD (2002) Applications of antisense and siRNAs during preclinical drug development. Drug Discov Today 7, 912–917

    Article  CAS  PubMed  Google Scholar 

  • Thornberry NA, and Lazebnik Y. (1998) Caspases: enemies within. Science. 281, 1312–1316.

    Article  CAS  PubMed  Google Scholar 

  • Tiscornia G, Singer O, Ikawa M, and Verma IM. (2003) A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci U S A. 100, 1844–1848.

    Article  CAS  PubMed  Google Scholar 

  • Troy CM, Rabacchi SA, Hohl JB, Angelastro JM, Greene LA, and Shelanski ML. (2001) Death in the balance: alternative participation of the caspase-2 and-9 pathways in neuronal death induced by nerve growth factor deprivation. J Neurosci. 21, 5007–5016.

    CAS  PubMed  Google Scholar 

  • Tsujimoto Y, and Croce CM. (1986) Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA. 83, 5214–5218.

    CAS  PubMed  Google Scholar 

  • Uhlmann E, Peyman A, Ryte A, Schmidt A, and Buddecke E. (2000) Use of minimally modified antisense oligonucleotides for specific inhibition of gene expression. Methods Enzymol. 13, 268–284.

    Google Scholar 

  • Uren AG, Wong L, Pakusch M, Fowler KJ, Burrows FJ, Vaux DL, and Choo KH. (2000) Survivin and the inner centromere protein INCENP show similar cell-cyclelocalization and gene knockout phenotype. Curr Biol. 10, 1319–1328.

    Article  CAS  PubMed  Google Scholar 

  • van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D, Holstege FC, Brummelkamp TR, Agami R, and Clevers H. (2003) Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 4, 609–615.

    PubMed  Google Scholar 

  • Vaux DL, Cory S, and Adams JM. (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335, 440–442.

    Article  CAS  PubMed  Google Scholar 

  • Vickers TA, Koo S, Bennett CF, Crooke ST, Dean NM, and Baker BF. (2003) Efficient reduction of target RNAs by small interfering RNA and RNAse H-dependent antisense agents. A comparative analysis. J Biol Chem. 278, 7108–7118.

    Article  CAS  PubMed  Google Scholar 

  • Vilenchik M, Raffo AJ, Benimetskaya L, Shames D, and Stein CA. (2002) Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents. Cancer Res. 62, 2175–2183.

    CAS  PubMed  Google Scholar 

  • Wang H, Cai Q, Zeng X, Yu D, Agrawal S, and Zhang R. (1999) Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration. Proc Natl Acad Sci U S A. 96, 13989–13994.

    CAS  PubMed  Google Scholar 

  • Wang J, Tekle E, Oubrahim H, Mieyal JJ, Stadtman ER, and Chock PB. (2003) Stable and controllable RNA interference: Investigating the physiological function of glutathionylated actin. Proc Natl Acad Sci U S A. 100, 5103–5106.

    CAS  PubMed  Google Scholar 

  • Wiese S, Digby MR, Gunnersen JM, Gotz R, Pei G, Holtmann B, Lowenthal J, and Sendtner M. (1999) The anti-apoptotic protein ITA is essential for NGF-mediated survival of embryonic chick neurons. Nat Neurosci. 2, 978–983.

    CAS  PubMed  Google Scholar 

  • Wilda M, Fuchs U, Wossmann W, and Borkhardt A (2002) Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 21, 5716–5724

    Article  CAS  PubMed  Google Scholar 

  • Williams NS, Gaynor RB, Scoggin S, Verma U, Gokaslan T, Simmang C, Fleming J, Tavana D, Frenkel E, and Becerra C. (2003) Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res. 9, 931–946.

    CAS  PubMed  Google Scholar 

  • Wright ME, Han DK, and Hockenbery DM. (2000) Caspase-3 and inhibitor of apoptosis protein(s) interactions in Saccharomyces cerevisiae and mammalian cells. FEBS Lett. 481, 13–18.

    Article  CAS  PubMed  Google Scholar 

  • Xia C, Xu Z, Yuan X, Uematsu K, You L, Li K, Li L, McCormick F, and Jablons DM. (2002) Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides. Mol Cancer Ther. 1, 687–694.

    CAS  PubMed  Google Scholar 

  • Xia H, Mao Q, Paulson HL, and Davidson BL. (2002) siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol. 20, 1006–1010.

    Article  CAS  PubMed  Google Scholar 

  • Xu Y, Zhang HY, Thormeyer D, Larsson O, Du Q, Elmen J, Wahlestedt C, and Liang Z. (2003) Effective small interfering RNAs and phosphorothioate antisense DNAs have different preferences for target sites in the luciferase mRNAs. Biochem Biophys Res Commun. 306, 712–717.

    CAS  PubMed  Google Scholar 

  • Yamamoto T, Manome Y, Nakamura M, and Tanigawa N. (2002) Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer. Eur J Cancer. 38, 2316–2324.

    Article  CAS  PubMed  Google Scholar 

  • Yu D, Zhu F-G, Bhagat L, Wang H, Kandimalla EK, Zhang R, and Agrawal S (2002) Potent CpG oligonucleotides containing phosphodiester linkages: in vitro and in vivo immunostimulatory properties. Biochem Biophys Res Commun 297, 83–90

    Article  CAS  PubMed  Google Scholar 

  • Yu JY, DeRuiter SL, and Turner DL. (2002) RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci U S A. 99, 6047–6052.

    CAS  PubMed  Google Scholar 

  • Zaffaroni N, and Daidone MG. (2002) Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions. Drug Resist Updat. 5, 65–72.

    CAS  PubMed  Google Scholar 

  • Zender L, Hutker S, Liedtke C, Tillmann HL, Zender S, Mundt B, Waltemathe M, Gosling T, Flemming P, Malek NP, Trautwein C, Manns MP, Kuhnel F, and Kubicka S. (2003) Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci U S A. 100, 7797–7802.

    Article  CAS  PubMed  Google Scholar 

  • Zhang HG, Huang N, Liu D, Bilbao L, Zhang X, Yang P, Zhou T, Curiel DT, and Mountz JD. (2000) Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts. Arthritis Rheum. 43, 1094–1105.

    Article  CAS  PubMed  Google Scholar 

  • Zhang HY, Mao J, Zhou D, Xu Y, Thonberg H, Liang Z, and Wahlestedt C. (2003) mRNA accessible site tagging (MAST): a novel high throughput method for selecting effective antisense oligonucleotides. Nucleic Acids Res. 31, e72.

    PubMed  Google Scholar 

  • Zhivotovsky B, and Orrenius S. (2003) Defects in the apoptotic machinery of cancer cells: role in drug resistance. Semin Cancer Biol. 13, 125–134.

    CAS  PubMed  Google Scholar 

  • Zhou W, and Agrawal S. (1998) Mixed-backbone oligonucleotides as second-generation antisense agents with reduced phosphorothioate-related side effects. Bioorg Med Chem Lett. 8, 3269–3274.

    Article  CAS  PubMed  Google Scholar 

  • Ziegler A, Simoes-Wuest AP, and Zangemeister-Wittke U. (2000) Optimizing efficacy of antisense oligodeoxynucleotides targeting inhibitors of apoptosis. Methods Enzymol. 314, 477–490

    CAS  PubMed  Google Scholar 

  • Zuker M. (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31, 3406–3415.

    Article  CAS  PubMed  Google Scholar 

  • Zuker M, Mathews DH, and Turner DH (1999) Algorithms and Thermodynamics for RNA Secondary Structure Prediction: A Practical Guide. In: RNA Biochemistry and Biotechnology, J. Barciszewski & B.F.C. Clark, eds., NATO ASI Series, Kluwer Academic Publishers.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Aegera Oncology Inc., Suite 2216, University of Ottawa, 451 Smyth Rd., Ottawa, ON, Canada, K1H 8M5

    E. Lacasse

Authors
  1. E. Lacasse
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Chemical Engineering, The University of Birmingham, Edgbaston, Birmingham, UK

    Mohamed Al-Rubeai

  2. Swiss Federal Institute of Technology, Zurich, Switzerland

    Martin Fussenegger

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Kluwer Academic Publishers

About this chapter

Cite this chapter

Lacasse, E. (2004). Apoptosis Control Based on Down-Regulating the Inhibitor-of-Apoptosis (IAP) Proteins: Xiap Antisense and Other Approaches. In: Al-Rubeai, M., Fussenegger, M. (eds) Cell Engineering. Cell Engineering, vol 4. Springer, Dordrecht. https://doi.org/10.1007/1-4020-2217-4_10

Download citation

Publish with us

Policies and ethics

Search

Navigation